Use of Sugammadex at the End of Case in Routine Anesthesia (MK-8616-023)

NCT00298831 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

224

Enrollment

INDUSTRY

Sponsor class

Conditions

Anesthesia, General

Interventions

DRUG: Sugammadex
DRUG: Rocuronium

Sponsor

Merck Sharp & Dohme LLC